KBP Biosciences, which is developing drugs for disease areas of unmet need, raised the series A funds from investors including Ping An Ventures.
Month: January 2018
Splend finds its Element
Element Fleet Management has invested $5.7m for a 12.5% stake in car rental service Splend together with $173m in debt financing.
Corporate venturing deal net: 1-5 January 2018
IDfy, an India-based background verification services provider backed by e-commerce company Beenos, has secured Rs 195m ($3.1m) in a round that included New Enterprise Associates (NEA), NB Ventures, and Dream Incubator, VCCircle reported on Tuesday, citing people aware of the development. The round came after IDfy had received $3m in 2015 from Beenos, NEA, Faktory… Continue reading Corporate venturing deal net: 1-5 January 2018
EarlySalary earns $15.8m in series B round
Mortgage provider Dewan Housing Finance has backed short-term loan provider EarlySalary, four months after investing in its series A round.
Rewind fast forwards to series A
Rewind Therapeutics, which is developing therapies for myelin-related diseases like MS, secured $18.3m in a Boehringer Ingelheim and Merck Group-backed round.
Cityblock attracts series A capital
Cityblock, a care coordination platform incubated by Alphabet-owned Sidewalk Labs, has raised $20.8m from investors including Sidewalk.
PGDx passes test to raise $75m
Bristol Myers-Squibb co-led the genomic testing technology provider’s series B round, which will support the expansion of its cancer tests to patients.
Intel joins Swarm64 for series B round
Data analytics software producer Swarm64 has raised $12.5m in a round that was co-led by Intel Capital, taking its total funding to more than $21m.
Choushu confirms Google-backed round
The game livestreaming platform has now raised $120m in total, putting the round’s size closer to $42m than the $76.8m previously reported.
WP Engine publishes $250m funding details
WP Engine, a WordPress software producer that counts WordPress operator Automattic as an investor, has raised $250m from Silver Lake.
Enterome swallows series D cash
Enterome, a France-based developer of treatments for gut microbiome-associated conditions, secured €32m ($38.5m) in series D funding yesterday from investors including pharmaceutical firms Bristol Myers-Squibb and Lundbeck. The round also featured food producer Nestlé’s Health Science unit, as well as Seventure, Health for Life Capital, Omnes Capital and Principia. Lundbeck invested through its corporate venturing… Continue reading Enterome swallows series D cash
SomaLogic measures out $200m
The deal was closed following commitments from Nan Fung Life Sciences and Madryn Asset Management, a year after iCarbonX made its anchor investment.
Rubikloud solves $37m series B puzzle
Intel Capital led a round for the retail analytics platform that included OpenText Enterprise Apps Fund and existing investor Access Industries
Editorial: Insights into the transport revolution
As China-based ride-hailing service Didi Chuxing’s acqures a majority of Brazil-based peer 99, below is a version of a speech presented in a keynote at the Corporate Venture in Brasil conference in October 2017.